Literature DB >> 10157428

Time preference, the discounted utility model and health.

H Bleichrodt1, A Gafni.   

Abstract

The constant rate discounted utility model is commonly used to represent intertemporal preferences in health care program evaluations. This paper examines the appropriateness of this model, and argues that the model fails both normatively and descriptively as a representation of individual intertemporal preferences for health outcomes. Variable rate discounted utility models are more flexible, but still require restrictive assumptions and may lead to dynamically inconsistent behaviour. The paper concludes by considering two ways of incorporating individual intertemporal preferences in health care program evaluations that allow for complementarity of health outcomes in different time periods.

Mesh:

Year:  1996        PMID: 10157428     DOI: 10.1016/0167-6296(95)00031-3

Source DB:  PubMed          Journal:  J Health Econ        ISSN: 0167-6296            Impact factor:   3.883


  6 in total

1.  Measurement of short term health effects in economic evaluations.

Authors:  A M Holmes
Journal:  Pharmacoeconomics       Date:  1998-02       Impact factor: 4.981

2.  Discounting health effects in pharmacoeconomic evaluations: current controversies.

Authors:  J M Bos; Maarten J Postma; Lieven Annemans
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

3.  On the (not so) constant proportional trade-off in TTO.

Authors:  Arthur E Attema; Werner B F Brouwer
Journal:  Qual Life Res       Date:  2010-02-12       Impact factor: 4.147

4.  Constantly proving the opposite? A test of CPTO using a broad time horizon and correcting for discounting.

Authors:  Arthur E Attema; Werner B F Brouwer
Journal:  Qual Life Res       Date:  2011-04-21       Impact factor: 4.147

5.  Are there socioeconomic disparities in women having discussions on human papillomavirus vaccine with health care providers?

Authors:  Ker Yi Wong; Young Kyung Do
Journal:  BMC Womens Health       Date:  2012-10-04       Impact factor: 2.809

6.  Funding of drugs: do vaccines warrant a different approach?

Authors:  Philippe Beutels; Paul A Scuffham; C Raina MacIntyre
Journal:  Lancet Infect Dis       Date:  2008-11       Impact factor: 25.071

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.